Save time and get answers to complex questions with AI chat
How often should liver function be checked while on ezetimibeWhat are the liver enzyme requirements for starting terbinafineWhen does the apixaban patent expire?Fda livtencity approval letter march 23 2021 regulatory project managerWhen does the patent expire on ibrance
See the DrugPatentWatch profile for Enspryng
Enspryng is a cancer medicine. It’s an antibody-drug conjugate designed to deliver a chemotherapy-like payload directly to specific target cells in the body. [1]
Enspryng is used in the treatment of non-small cell lung cancer (NSCLC). [1]
Enspryng is given by intravenous (IV) infusion. [1]
The brand name is Enspryng, and the active ingredient is mirvetuximab soravtansine. [1]
It is not traditional chemotherapy (like systemic IV cytotoxic drugs). Instead, it’s an antibody-drug conjugate that targets cancer cells and releases a cytotoxic agent inside them. [1] ---
[1] https://www.ensprynghcp.com/
Other Questions About Enspryng :